By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Response BioPharma  



     
Phone: Fax:


SEARCH JOBS








Company News
Immune Response BioPharma Posts Record 1st Half 2014 Results 7/14/2014 8:50:22 AM
Immune Response BioPharma Selects Seppic To Supply IFA For REMUNE Vaccine Commercialization 6/20/2014 8:45:02 AM
Immune Response BioPharma Announces FDA BLA Fee Waiver Granted Clears Path For REMUNE Approval 4/2/2014 9:14:46 AM
Immune Response BioPharma Announces NeuroVax Granted Fast Track FDA Designation For SPMS 3/21/2014 2:30:39 PM
Immune Response BioPharma Posts 2nd Half & Full Year 2013 Results 2/24/2014 9:18:40 AM
Immune Response BioPharma Announces REMUNE Granted Orphan Designation For Pediatric HIV/AIDS 2/18/2014 9:07:48 AM
Immune Response BioPharma Announces NeuroVax Granted Orphan Designation For Pediatric MS 2/10/2014 9:17:16 AM
Immune Response BioPharma Sets U.S. REMUNE Pricing Range $75-250 Per Dose 12/27/2013 8:02:18 AM
Immune Response BioPharma To Develop Annual HIV Vaccine RemuneVax Based On Current HIV Strain 12/23/2013 10:36:05 AM
Immune Response BioPharma To File Remune BLA With FDA By March 1st 2014 Submits Fee Waiver Request 12/3/2013 8:32:16 AM
123456
//-->